Skip to main content
Erschienen in: Journal of Diabetes & Metabolic Disorders 2/2023

22.05.2023 | Research article

‘Inequalities in prevalence of hypertension, prehypertension, anti-hypertensive coverage, awareness, and effective treatment in 429 districts of Iran; a population-based STEPS 2016 small area spatial estimation model’

verfasst von: Esmaeil Mohammadi, Moein Yoosefi, Elaheh Shaker, Elnaz Shahmohamadi, Erfan Ghasemi, Naser Ahmadi, Sina Azadnajafabad, Mohammad-Mahdi Rashidi, Nazila Rezaei, Sogol Koolaji, Arezou Dilmaghani-Marand, Sahar Mohammadi Fateh, Ameneh Kazemi, Rosa Haghshenas, Negar Rezaei

Erschienen in: Journal of Diabetes & Metabolic Disorders | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

While many studies have reported hypertension (HTN) and pre-hypertension (PHTN) in large geographic locations of Iran, information regarding district levels is missing. We aimed to examine inequalities in the prevalence of hypertension, prehypertension, anti-hypertensive coverage, awareness, and effective treatment of adults in districts of Iran.

Methods

We used 27,165 participants’ data from the STEPS 2016 study in Iran. A small area estimation model was carried out to predict HTN in the 429 districts of Iran. HTN and PHTN were defined based on the American Heart Association Guideline. Awareness of being hypertensive, treatment coverage, and effective treatment were also estimated.

Results

HTN’s crude prevalence was estimated to be in the range of 11.5–42.2% in districts. About PHTN, it was estimated to be 19.9–56.1%. Moreover, for awareness, treatment coverage, and effective treatment crude estimates ranged from 24.3 to 79.9%, 9.1 – 64.6%, and 19.5 – 68.3%, respectively, indicating inequalities in the distribution of aforementioned variables in 429 districts of Iran. Overall, better conditions were detected in central geographical locations and in females.

Conclusion

The inequality of increased blood pressure disorder and related measures are high in districts of Iran and pave the way for policymakers and local health organizers to use the findings of this study to address the inequity of existing resources and improve HTN control.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Esteghamati A, Abbasi M, Alikhani S, Gouya MM, Delavari A, Shishehbor MH, et al. Prevalence, awareness, treatment, and risk factors associated with hypertension in the iranian population: the national survey of risk factors for noncommunicable diseases of Iran. Am J Hypertens. 2008;21(6):620–6.PubMed Esteghamati A, Abbasi M, Alikhani S, Gouya MM, Delavari A, Shishehbor MH, et al. Prevalence, awareness, treatment, and risk factors associated with hypertension in the iranian population: the national survey of risk factors for noncommunicable diseases of Iran. Am J Hypertens. 2008;21(6):620–6.PubMed
2.
Zurück zum Zitat Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. The lancet. 2005;365(9455):217–23. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. The lancet. 2005;365(9455):217–23.
3.
Zurück zum Zitat Lackland DT, Weber MA. Global burden of cardiovascular disease and stroke: hypertension at the core. Can J Cardiol. 2015;31(5):569–71.PubMed Lackland DT, Weber MA. Global burden of cardiovascular disease and stroke: hypertension at the core. Can J Cardiol. 2015;31(5):569–71.PubMed
4.
Zurück zum Zitat Mensah GA. The global burden of hypertension: good news and bad news. Cardiol Clin. 2002;20(2):181–5.PubMed Mensah GA. The global burden of hypertension: good news and bad news. Cardiol Clin. 2002;20(2):181–5.PubMed
5.
Zurück zum Zitat Mirzaei M, Moayedallaie S, Jabbari L, Mohammadi M. Prevalence of hypertension in Iran 1980–2012: a systematic review. J Tehran Univ Heart Cent. 2016;11(4):159. Mirzaei M, Moayedallaie S, Jabbari L, Mohammadi M. Prevalence of hypertension in Iran 1980–2012: a systematic review. J Tehran Univ Heart Cent. 2016;11(4):159.
6.
Zurück zum Zitat Drouin D, Campbell NR, Kaczorowski J, Program CHE. Implementation of recommendations on hypertension: the canadian Hypertension Education Program. Can J Cardiol. 2006;22(7):595–8.PubMedPubMedCentral Drouin D, Campbell NR, Kaczorowski J, Program CHE. Implementation of recommendations on hypertension: the canadian Hypertension Education Program. Can J Cardiol. 2006;22(7):595–8.PubMedPubMedCentral
7.
Zurück zum Zitat Anderson KM, Odell PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121(1, Part 2):293–8.PubMed Anderson KM, Odell PM, Wilson PWF, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121(1, Part 2):293–8.PubMed
8.
Zurück zum Zitat Samuelsson O, Wilhelmsen L, Elmfeldt D, Pennert K, Wedel H, Wikstrand J, et al. Predictors of cardiovascular morbidity in treated hypertension: results from the primary preventive trial in Göteborg, Sweden. J Hypertens. 1985;3(2):167–76.PubMed Samuelsson O, Wilhelmsen L, Elmfeldt D, Pennert K, Wedel H, Wikstrand J, et al. Predictors of cardiovascular morbidity in treated hypertension: results from the primary preventive trial in Göteborg, Sweden. J Hypertens. 1985;3(2):167–76.PubMed
9.
Zurück zum Zitat Passi-Solar Á, Margozzini P, Mindell JS, Ruiz M, Valencia-Hernandez CA, Scholes S. Hypertension care cascade in Chile: a serial cross-sectional study of national health surveys 2003-2010-2017. BMC Public Health. 2020;20(1):1–11. Passi-Solar Á, Margozzini P, Mindell JS, Ruiz M, Valencia-Hernandez CA, Scholes S. Hypertension care cascade in Chile: a serial cross-sectional study of national health surveys 2003-2010-2017. BMC Public Health. 2020;20(1):1–11.
10.
Zurück zum Zitat Geraedts TJ, Boateng D, Lindenbergh KC, van Delft D, Mathéron HM, Mönnink GL, et al. Evaluating the cascade of care for hypertension in Sierra Leone. Tropical Med Int Health. 2021;26(11):1470–80. Geraedts TJ, Boateng D, Lindenbergh KC, van Delft D, Mathéron HM, Mönnink GL, et al. Evaluating the cascade of care for hypertension in Sierra Leone. Tropical Med Int Health. 2021;26(11):1470–80.
11.
Zurück zum Zitat Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar A-A, Hekmatdoost A, et al. Prospective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): Rationale, objectives, and design. Am J Epidemiol. 2018;187(4):647–55.PubMed Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar A-A, Hekmatdoost A, et al. Prospective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): Rationale, objectives, and design. Am J Epidemiol. 2018;187(4):647–55.PubMed
12.
Zurück zum Zitat Murray CJL, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020;396(10258):1223–49. Murray CJL, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020;396(10258):1223–49.
13.
Zurück zum Zitat Larki A, Tahmasebi R, Reisi M. Factors predicting self-care behaviors among low health literacy hypertensive patients based on health belief model in Bushehr District, South of Iran. International journal of hypertension. 2018;2018. Larki A, Tahmasebi R, Reisi M. Factors predicting self-care behaviors among low health literacy hypertensive patients based on health belief model in Bushehr District, South of Iran. International journal of hypertension. 2018;2018.
14.
Zurück zum Zitat Rafraf M, Gargari BP, Safaiyan A. Prevalence of prehypertension and hypertension among adolescent high school girls in Tabriz, Iran. FoodNutr Bull. 2010;31(3):461–5. Rafraf M, Gargari BP, Safaiyan A. Prevalence of prehypertension and hypertension among adolescent high school girls in Tabriz, Iran. FoodNutr Bull. 2010;31(3):461–5.
15.
Zurück zum Zitat Taheri F, Namakin K, Kazemi T, Chahkandi T, Bijari B, Zardast M. The prevalence of high blood pressure among children aged 11–18 years in Birjand district, Eastern Iran in 2012: a cross-sectional study. Int J School Health. 2014;1(2):1–4. Taheri F, Namakin K, Kazemi T, Chahkandi T, Bijari B, Zardast M. The prevalence of high blood pressure among children aged 11–18 years in Birjand district, Eastern Iran in 2012: a cross-sectional study. Int J School Health. 2014;1(2):1–4.
16.
Zurück zum Zitat Talaei M, Sadeghi M, Mohammadifard N, Shokouh P, Oveisgharan S, Sarrafzadegan N. Incident hypertension and its predictors: the Isfahan Cohort Study. J Hypertens. 2014;32(1):30–8.PubMed Talaei M, Sadeghi M, Mohammadifard N, Shokouh P, Oveisgharan S, Sarrafzadegan N. Incident hypertension and its predictors: the Isfahan Cohort Study. J Hypertens. 2014;32(1):30–8.PubMed
17.
Zurück zum Zitat Allameh M, Ghanei Gheshlagh R, Rahmani K. Prevalence and Associated Risk Factors of Hypertension for the Middle-Aged Population (30–59 Years) in Iran: A National Cross-Sectional Study.High Blood Pressure & Cardiovascular Prevention. 2021:1–6. Allameh M, Ghanei Gheshlagh R, Rahmani K. Prevalence and Associated Risk Factors of Hypertension for the Middle-Aged Population (30–59 Years) in Iran: A National Cross-Sectional Study.High Blood Pressure & Cardiovascular Prevention. 2021:1–6.
18.
Zurück zum Zitat Djalalinia S, Modirian M, Sheidaei A, Yoosefi M, Zokaiee H, Damirchilu B, et al. Protocol Design for large-scale cross-sectional studies of Surveillance of Risk factors of non-communicable Diseases in Iran: STEPs 2016. Arch Iran Med. 2017;20(9):608–16.PubMed Djalalinia S, Modirian M, Sheidaei A, Yoosefi M, Zokaiee H, Damirchilu B, et al. Protocol Design for large-scale cross-sectional studies of Surveillance of Risk factors of non-communicable Diseases in Iran: STEPs 2016. Arch Iran Med. 2017;20(9):608–16.PubMed
20.
Zurück zum Zitat Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH et al. /ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension (Dallas, Tex: 1979). 2018;71(6):1269 – 324. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH et al. /ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension (Dallas, Tex: 1979). 2018;71(6):1269 – 324.
21.
Zurück zum Zitat Pfeffermann D. New important developments in small area estimation. Stat Sci. 2013;28(1):40–68. Pfeffermann D. New important developments in small area estimation. Stat Sci. 2013;28(1):40–68.
22.
Zurück zum Zitat Azadnajafabad S, Ebrahimi N, Mohammadi E, Ghasemi E, Saeedi Moghaddam S, Aminorroaya A, et al. Disparities and spatial variations of high salt intake in Iran: a subnational study of districts based on the small area estimation method. Public Health Nutr. 2021;24(18):6281–91.PubMed Azadnajafabad S, Ebrahimi N, Mohammadi E, Ghasemi E, Saeedi Moghaddam S, Aminorroaya A, et al. Disparities and spatial variations of high salt intake in Iran: a subnational study of districts based on the small area estimation method. Public Health Nutr. 2021;24(18):6281–91.PubMed
23.
Zurück zum Zitat Mahdavi M, Parsaeian M, Mohajer B, Modirian M, Ahmadi N, Yoosefi M, et al. Insight into blood pressure targets for universal coverage of hypertension services in Iran: the 2017 ACC/AHA versus JNC 8 hypertension guidelines. BMC Public Health. 2020;20(1):1–9. Mahdavi M, Parsaeian M, Mohajer B, Modirian M, Ahmadi N, Yoosefi M, et al. Insight into blood pressure targets for universal coverage of hypertension services in Iran: the 2017 ACC/AHA versus JNC 8 hypertension guidelines. BMC Public Health. 2020;20(1):1–9.
24.
Zurück zum Zitat Armstrong C. JNC8 guidelines for the management of hypertension in adults. Am Fam Physician. 2014;90(7):503–4.PubMed Armstrong C. JNC8 guidelines for the management of hypertension in adults. Am Fam Physician. 2014;90(7):503–4.PubMed
25.
Zurück zum Zitat HAGHDOUST A, Sadeghirad B, REZAZADEH KM. Epidemiology and heterogeneity of hypertension in Iran: a systematic review. 2008. HAGHDOUST A, Sadeghirad B, REZAZADEH KM. Epidemiology and heterogeneity of hypertension in Iran: a systematic review. 2008.
26.
Zurück zum Zitat Ebrahimi M, Mansournia MA, Haghdoost AA, Abazari A, Alaeddini F, Mirzazadeh A, et al. Social disparities in prevalence, treatment and control of hypertension in Iran: second National Surveillance of Risk factors of noncommunicable Diseases, 2006. J Hypertens. 2010;28(8):1620–9.PubMed Ebrahimi M, Mansournia MA, Haghdoost AA, Abazari A, Alaeddini F, Mirzazadeh A, et al. Social disparities in prevalence, treatment and control of hypertension in Iran: second National Surveillance of Risk factors of noncommunicable Diseases, 2006. J Hypertens. 2010;28(8):1620–9.PubMed
27.
Zurück zum Zitat Islam SMS, Purnat TD, Phuong NTA, Mwingira U, Schacht K, Fröschl G. Non-Communicable Diseases (NCDs) in developing countries: a symposium report. Globalization and health. 2014;10(1):1–8. Islam SMS, Purnat TD, Phuong NTA, Mwingira U, Schacht K, Fröschl G. Non-Communicable Diseases (NCDs) in developing countries: a symposium report. Globalization and health. 2014;10(1):1–8.
28.
Zurück zum Zitat Hosseini M, Yousefifard M, Baikpour M, Rafei A, Fayaz M, Heshmat R, et al. Twenty-year dynamics of hypertension in iranian adults: age, period, and cohort analysis. J Am Soc Hypertens. 2015;9(12):925–34.PubMed Hosseini M, Yousefifard M, Baikpour M, Rafei A, Fayaz M, Heshmat R, et al. Twenty-year dynamics of hypertension in iranian adults: age, period, and cohort analysis. J Am Soc Hypertens. 2015;9(12):925–34.PubMed
29.
Zurück zum Zitat Elliott WJ, Black HR, Prehypertension. Nat Clin Pract Cardiovasc Med. 2007;4(10):538–48.PubMed Elliott WJ, Black HR, Prehypertension. Nat Clin Pract Cardiovasc Med. 2007;4(10):538–48.PubMed
30.
Zurück zum Zitat Egan BM, Stevens-Fabry S. Prehypertension—prevalence, health risks, and management strategies. Nat Reviews Cardiol. 2015;12(5):289–300. Egan BM, Stevens-Fabry S. Prehypertension—prevalence, health risks, and management strategies. Nat Reviews Cardiol. 2015;12(5):289–300.
31.
Zurück zum Zitat Svetkey LP. Management of prehypertension. Hypertension (Dallas, Tex: 1979). 2005;45(6):1056-61. Svetkey LP. Management of prehypertension. Hypertension (Dallas, Tex: 1979). 2005;45(6):1056-61.
32.
Zurück zum Zitat Dong G-H, Wang D, Liu M-M, Liu Y-Q, Zhao Y, Yang M, et al. Sex difference of the prevalence and risk factors associated with prehypertension among urban chinese adults from 33 communities of China: the CHPSNE study. J Hypertens. 2012;30(3):485–91.PubMed Dong G-H, Wang D, Liu M-M, Liu Y-Q, Zhao Y, Yang M, et al. Sex difference of the prevalence and risk factors associated with prehypertension among urban chinese adults from 33 communities of China: the CHPSNE study. J Hypertens. 2012;30(3):485–91.PubMed
33.
Zurück zum Zitat Qureshi AI, Suri FK, Kirmani JF, Divani AA. Prevalence and trends of prehypertension and hypertension in United States: National Health and Nutrition examination surveys 1976 to 2000. Med Sci Monit. 2005;11(9):CR403–CR9.PubMed Qureshi AI, Suri FK, Kirmani JF, Divani AA. Prevalence and trends of prehypertension and hypertension in United States: National Health and Nutrition examination surveys 1976 to 2000. Med Sci Monit. 2005;11(9):CR403–CR9.PubMed
34.
Zurück zum Zitat Najafipour H, Nasri HR, Afshari M, Moazenzadeh M, Shokoohi M, Foroud A, et al. Hypertension: diagnosis, control status and its predictors in general population aged between 15 and 75 years: a community-based study in southeastern Iran. Int J public health. 2014;59(6):999–1009.PubMed Najafipour H, Nasri HR, Afshari M, Moazenzadeh M, Shokoohi M, Foroud A, et al. Hypertension: diagnosis, control status and its predictors in general population aged between 15 and 75 years: a community-based study in southeastern Iran. Int J public health. 2014;59(6):999–1009.PubMed
35.
Zurück zum Zitat Kaona FAD, Tuba M, Siziya S, Sikaona L. An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health. 2004;4(1):68.PubMedPubMedCentral Kaona FAD, Tuba M, Siziya S, Sikaona L. An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health. 2004;4(1):68.PubMedPubMedCentral
36.
Zurück zum Zitat Heydari A, Ziaee ES, Gazrani A. Relationship between awareness of Disease and Adherence to Therapeutic Regimen among Cardiac Patients. Int J Community Based Nurs Midwifery. 2015;3(1):23–30.PubMedPubMedCentral Heydari A, Ziaee ES, Gazrani A. Relationship between awareness of Disease and Adherence to Therapeutic Regimen among Cardiac Patients. Int J Community Based Nurs Midwifery. 2015;3(1):23–30.PubMedPubMedCentral
37.
Zurück zum Zitat Strömberg A. Patient-related factors of compliance in heart failure: some new insights into an old problem. Eur Heart J. 2006;27(4):379–81.PubMed Strömberg A. Patient-related factors of compliance in heart failure: some new insights into an old problem. Eur Heart J. 2006;27(4):379–81.PubMed
38.
Zurück zum Zitat Misra AK, Sharma A, Shukla JB. Modeling and analysis of effects of awareness programs by media on the spread of infectious diseases. Math Comput Model. 2011;53(5):1221–8. Misra AK, Sharma A, Shukla JB. Modeling and analysis of effects of awareness programs by media on the spread of infectious diseases. Math Comput Model. 2011;53(5):1221–8.
39.
Zurück zum Zitat Leonardo Alves T, Martins de Freitas AF, van Eijk MEC, Mantel-Teeuwisse AK. Compliance of Disease Awareness Campaigns in printed dutch media with National and International Regulatory Guidelines. PLoS ONE. 2014;9(9):e106599.PubMedPubMedCentral Leonardo Alves T, Martins de Freitas AF, van Eijk MEC, Mantel-Teeuwisse AK. Compliance of Disease Awareness Campaigns in printed dutch media with National and International Regulatory Guidelines. PLoS ONE. 2014;9(9):e106599.PubMedPubMedCentral
40.
Zurück zum Zitat Sarafidis PA, Bakris GL. State of hypertension management in the United States: confluence of risk factors and the prevalence of resistant hypertension. J Clin Hypertens. 2008;10(2):130–9. Sarafidis PA, Bakris GL. State of hypertension management in the United States: confluence of risk factors and the prevalence of resistant hypertension. J Clin Hypertens. 2008;10(2):130–9.
41.
Zurück zum Zitat Guo F, He D, Zhang W, Walton RG. Trends in Prevalence, Awareness, Management, and control of Hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol. 2012;60(7):599.PubMed Guo F, He D, Zhang W, Walton RG. Trends in Prevalence, Awareness, Management, and control of Hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol. 2012;60(7):599.PubMed
42.
Zurück zum Zitat Hou Z, Meng Q, Zhang Y, Hypertension Prevalence. Awareness, treatment, and Control following China’s Healthcare Reform. Am J Hypertens. 2016;29(4):428–31.PubMed Hou Z, Meng Q, Zhang Y, Hypertension Prevalence. Awareness, treatment, and Control following China’s Healthcare Reform. Am J Hypertens. 2016;29(4):428–31.PubMed
43.
Zurück zum Zitat Gasse C, Hense HW, Stieber J, Döring A, Liese AD, Keil U. Assessing hypertension management in the community: trends of prevalence, detection, treatment, and control of hypertension in the MONICA Project, Augsburg 1984–1995. J Hum Hypertens. 2001;15(1):27–36.PubMed Gasse C, Hense HW, Stieber J, Döring A, Liese AD, Keil U. Assessing hypertension management in the community: trends of prevalence, detection, treatment, and control of hypertension in the MONICA Project, Augsburg 1984–1995. J Hum Hypertens. 2001;15(1):27–36.PubMed
44.
Zurück zum Zitat Meisinger C, Heier M, Völzke H, Löwel H, Mitusch R, Hense H-W et al. Regional disparities of hypertension prevalence and management within Germany. J Hypertens. 2006;24(2). Meisinger C, Heier M, Völzke H, Löwel H, Mitusch R, Hense H-W et al. Regional disparities of hypertension prevalence and management within Germany. J Hypertens. 2006;24(2).
45.
Zurück zum Zitat Pereira M, Lunet N, Azevedo A, Barros H. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens. 2009;27(5). Pereira M, Lunet N, Azevedo A, Barros H. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens. 2009;27(5).
46.
Zurück zum Zitat Delavar A, Horri N, Haghighi S, Alikhani S, Mahdavi A, Hosseini SM et al. Hypertension and pre-hypertension: prevalence, awareness and management among iranian adults older than 20 years. Journal of medical council of iri. 2007;24(4):372 –80. Delavar A, Horri N, Haghighi S, Alikhani S, Mahdavi A, Hosseini SM et al. Hypertension and pre-hypertension: prevalence, awareness and management among iranian adults older than 20 years. Journal of medical council of iri. 2007;24(4):372 –80.
47.
Zurück zum Zitat Geldsetzer P, Manne-Goehler J, Marcus M-E, Ebert C, Zhumadilov Z, Wesseh CS, et al. The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults. The Lancet. 2019;394(10199):652–62. Geldsetzer P, Manne-Goehler J, Marcus M-E, Ebert C, Zhumadilov Z, Wesseh CS, et al. The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults. The Lancet. 2019;394(10199):652–62.
48.
Zurück zum Zitat Hanachi P, Ali PN, Rezayi N, Latiff LA. Comparison of physiological and psychological well-being in physical active and sedentary women in Iran. Global J Health Sci. 2010;2(2):249. Hanachi P, Ali PN, Rezayi N, Latiff LA. Comparison of physiological and psychological well-being in physical active and sedentary women in Iran. Global J Health Sci. 2010;2(2):249.
49.
Zurück zum Zitat Amanolahi S. Fieldwork among pastoral nomads and in sedentary communities of Iran. Iran Stud. 2004;37(4):613–21. Amanolahi S. Fieldwork among pastoral nomads and in sedentary communities of Iran. Iran Stud. 2004;37(4):613–21.
50.
Zurück zum Zitat Tavousi M, Haeri Mehrizi A, Rafiefar S, Solimanian A, Sarbandi F, Ardestani M, et al. HEALTH LITERACY IN IRAN: FINDINGS FROM A NATIONAL STUDY. PAYESH. 2016;15(1):95–102. Tavousi M, Haeri Mehrizi A, Rafiefar S, Solimanian A, Sarbandi F, Ardestani M, et al. HEALTH LITERACY IN IRAN: FINDINGS FROM A NATIONAL STUDY. PAYESH. 2016;15(1):95–102.
51.
Zurück zum Zitat Azadnajafabad S, Saeedi Moghaddam S, Rezaei N, Ghasemi E, Naderimagham S, Azmin M et al. A report on statistics of an online self-screening platform for COVID-19 and its effectiveness in Iran. International Journal of Health Policy and Management. 2021. Azadnajafabad S, Saeedi Moghaddam S, Rezaei N, Ghasemi E, Naderimagham S, Azmin M et al. A report on statistics of an online self-screening platform for COVID-19 and its effectiveness in Iran. International Journal of Health Policy and Management. 2021.
52.
Zurück zum Zitat Keykhaei M, Koolaji S, Mohammadi E, Kalantar R, Saeedi Moghaddam S, Aminorroaya A, et al. Dissection of non-pharmaceutical interventions implemented by Iran, South Korea, and Turkey in the fight against COVID-19 pandemic. J Diabetes Metabolic Disorders. 2021;20(2):1919–31. Keykhaei M, Koolaji S, Mohammadi E, Kalantar R, Saeedi Moghaddam S, Aminorroaya A, et al. Dissection of non-pharmaceutical interventions implemented by Iran, South Korea, and Turkey in the fight against COVID-19 pandemic. J Diabetes Metabolic Disorders. 2021;20(2):1919–31.
53.
Zurück zum Zitat Madani S, Shahin S, Yoosefi M, Ahmadi N, Ghasemi E, Koolaji S, et al. Red flags of poor prognosis in pediatric cases of COVID-19: the first 6610 hospitalized children in Iran. BMC Pediatr. 2021;21(1):1–9. Madani S, Shahin S, Yoosefi M, Ahmadi N, Ghasemi E, Koolaji S, et al. Red flags of poor prognosis in pediatric cases of COVID-19: the first 6610 hospitalized children in Iran. BMC Pediatr. 2021;21(1):1–9.
54.
Zurück zum Zitat Mohammadi E, Azmin M, Fattahi N, Ghasemi E, Azadnajafabad S, Rezaei N, et al. A pilot study using financial transactions’ spatial information to define high-risk neighborhoods and distribution pattern of COVID-19. Digit Health. 2022;8:20552076221076252.PubMedPubMedCentral Mohammadi E, Azmin M, Fattahi N, Ghasemi E, Azadnajafabad S, Rezaei N, et al. A pilot study using financial transactions’ spatial information to define high-risk neighborhoods and distribution pattern of COVID-19. Digit Health. 2022;8:20552076221076252.PubMedPubMedCentral
55.
Zurück zum Zitat Rezaei N, Montazeri F, Malekpour M-R, Ghanbari A, Azadnajafabad S, Mohammadi E, et al. COVID-19 in patients with diabetes: factors associated with worse outcomes. J Diabetes Metabolic Disorders. 2021;20(2):1605–14. Rezaei N, Montazeri F, Malekpour M-R, Ghanbari A, Azadnajafabad S, Mohammadi E, et al. COVID-19 in patients with diabetes: factors associated with worse outcomes. J Diabetes Metabolic Disorders. 2021;20(2):1605–14.
Metadaten
Titel
‘Inequalities in prevalence of hypertension, prehypertension, anti-hypertensive coverage, awareness, and effective treatment in 429 districts of Iran; a population-based STEPS 2016 small area spatial estimation model’
verfasst von
Esmaeil Mohammadi
Moein Yoosefi
Elaheh Shaker
Elnaz Shahmohamadi
Erfan Ghasemi
Naser Ahmadi
Sina Azadnajafabad
Mohammad-Mahdi Rashidi
Nazila Rezaei
Sogol Koolaji
Arezou Dilmaghani-Marand
Sahar Mohammadi Fateh
Ameneh Kazemi
Rosa Haghshenas
Negar Rezaei
Publikationsdatum
22.05.2023
Verlag
Springer International Publishing
Erschienen in
Journal of Diabetes & Metabolic Disorders / Ausgabe 2/2023
Elektronische ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-023-01186-5

Weitere Artikel der Ausgabe 2/2023

Journal of Diabetes & Metabolic Disorders 2/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.